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Abstract
Background: Hepatitis C virus (HCV), like other positive-sense RNA viruses, replicates on an altered host membrane
compartment that has been called the ‘‘membranous web.’’ The mechanisms by which the membranous web are formed
from cellular membranes are poorly understood. Several recent RNA interference screens have demonstrated a critical role
for the host phosphatidylinositol 4-kinase PI4KA in HCV replication. We have sought to define the function of PI4KA in viral
replication.
Methodology/Principal Findings: Using a nonreplicative model of membranous web formation, we show that PI4KA
silencing leads to aberrant web morphology. Furthermore, we find that PI4KA and its product, phosphatidylinositol 4-
phosphate, are enriched on membranous webs and that PI4KA is found in association with NS5A in HCV-infected cells.
While the related lipid kinase PI4KB also appears to support HCV replication, it does not interact with NS5A. Silencing of
PI4KB does not overtly impair membranous web morphology or phosphatidylinositol 4-phosphate enrichment at webs,
suggesting that it acts at a different point in viral replication. Finally, we demonstrate that the aberrant webs induced by
PI4KA silencing require the activity of the viral NS3-4A serine protease but not integrity of the host secretory pathway.
Conclusions/Significance: PI4KA is necessary for the local enrichment of PI 4-phosphate at the HCV membranous web and
for the generation of morphologically normal webs. We also show that nonreplicative systems of web formation can be
used to order molecular events that drive web assembly.
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Introduction
Hepatitis C virus (HCV) is a positive-sense ssRNA virus that is
estimated to chronically infect as many as 3% of the world’s
population, of whom up to 30% will progress to cirrhosis. As a
result, HCV-related liver disease (principally liver failure and
hepatocellular carcinoma) is the leading indication for liver
transplantation worldwide. Recent drug development strategies
to combat HCV infection have largely focused on the viral NS3-
4A serine protease and NS5B RNA polymerase, although viral
resistance remains a concern due to the error-prone nature of the
viral polymerase [1]. We have instead focused on defining the host
cofactors that support the viral lifecycle, as blocking cellular
cofactors may impose a higher barrier to resistance and may
permit the targeting of multiple steps in the viral lifecycle.
A number of RNAi screens for host cofactors of HCV
replication have identified a critical role for the phosphatidylino-
sitol (PI) 4-kinase PI4KA in HCV replication e.g. [2–6]. Four
different mammalian PI 4-kinases have been identified (reviewed
in [7]), which all catalyze the conversion of PI to PI 4-phosphate.
PI(4)P is believed to exert its functions through the binding of a
number of effector proteins, including the coat adaptor AP-1 [8]
and lipid transfer proteins such as OSBP1 and CERT (reviewed in
[9]). Intriguingly, the related PI 4-kinase PI4KB has recently been
shown to be required for enterovirus replication [10], suggesting a
common dependence of at least some positive-sense ssRNA viruses
on host PI(4)P metabolism. In particular, all positive-sense ssRNA
viruses studied to date replicate on altered cellular membrane
compartments, which in the case of HCV has been termed the
‘‘membranous web’’ [11].
Little is known about the mechanisms that direct HCV
membranous web formation. While the membranous web is
generally believed to be derived from the host endoplasmic
reticulum (ER), it is a detergent-resistant membrane [12] and has
also been shown to be associated with early endocytic markers
such as Rab5 [13], suggesting that the membranous web is highly
modified from its membrane(s) of origin. We lack a precise
understanding of the molecular events that transform the host ER
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in web formation have not been characterized.
We have sought to determine the mechanisms by which PI4KA
and PI(4)P support HCV replication. Because HCV polyprotein
translation is coupled to RNA replication, silencing of essential
host cofactors such as PI4KA leads to the rapid loss of HCV
polyprotein translation in authentic replication systems (replicons
or infectious virus). As a result, blocks in membranous web
assembly are difficult or impossible to identify in replication-
dependent HCV expression systems but may be recognizable in
nonreplicative HCV expression systems. We had previously found
that PI4KA silencing in U2-OS osteosarcoma cells inducibly
expressing a full-length HCV polyprotein [14] led to abnormal
NS5A-positive membrane clusters [2]. However, U2-OS cells do
not support efficient HCV replication, and so we sought to
establish a replication-independent HCV expression system in the
more physiologically relevant Huh7 hepatoma cell line. Using a
T7 RNA polymerase-driven system of HCV polyprotein expres-
sion, we show that PI4KA is required for the formation of
membranous webs, and that PI4KA and its product PI(4)P are
enriched at HCV replication sites. We also identify a potential
intermediate of web formation that is generated in the absence of
PI4KA activity; furthermore, we show that this intermediate
requires viral NS3-4A serine protease activity but not brefeldin A-
sensitive host factors, which are known to support viral replication.
In principle, the methodologies used in this work can be applied to
study other events in HCV membranous web formation.
Materials and Methods
Reagents
Antibodies used included those directed against annexin A2
(rabbit polyclonal, Santa Cruz Biotechnology, Santa Cruz, CA),
the FLAG epitope tag (mouse monoclonal clone M2; Sigma-
Aldrich, St. Louis, MO), myc tag (mouse monoclonal clone 9E10;
Sigma-Aldrich), PI4KA (rabbit polyclonal, Cell Signaling, Dan-
vers, MA), PI4KB (rabbit polyclonal, Abcam, Cambridge, MA),
PI(4)P (mouse IgM monoclonal, Echelon, Salt Lake City, UT),
HCV NS5A (mouse monoclonal clone 9E10; Dr. Charles Rice,
Rockefeller University, New York, NY), HCV NS3 (mouse
monoclonal, ViroGen, Watertown, MA), and HCV NS4B (mouse
monoclonal, Abcam).
Cell lines and cell culture
Huh7.5.1 cells [15] were grown in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), nonessential amino acids, 100 U/mL of penicillin, and
100 mg/mL of streptomycin. OR6 cells containing a full-length
genotype 1b HCV replicon [16] and SGR-JFH1 genotype 2a
subgenomic replicon cells [17] were grown in the same medium
with the addition of 400 mg/mL G418.
Expression of HCV nonstructural proteins using T7 RNA
polymerase
The JFH1 sequence from NS3 through NS5B, which is
necessary and sufficient for membranous web formation and viral
RNA replication, was subcloned from the pSGR-JFH1 subge-
nomic replicon construct [17] into the pTM1 vector [18] in two
steps. The pTM1 vector was designed for T7 RNA polymerase-
driven protein expression and contains a T7 promoter and EMCV
IRES upstream of a multiple-cloning site and T7 transcriptional
terminator. In the first step, the NcoI-NcoI fragment from pSGR-
JFH1 was ligated into the NcoI restriction site in pTM1 at the
immediate 39 end of the EMCV IRES. In the second step, the
SpeI-XbaI fragment from pSGR-JFH1 or from pSGR-JFH1
(NS5A-GFP) was ligated into SpeI-digested pTM1 vector
containing the NcoI-NcoI fragment to generate pTM1(NS3-5B)
and pTM1(NS3-5B/GFP), respectively. The correct orientations
of the NcoI-NcoI and SpeI-XbaI fragments were confirmed by
restriction enzyme mapping and by sequencing of the termini. To
construct pSGR-JFH1(NS5A-GFP), we amplified the EGFP
sequence with flanking MluI restriction sites (primers in Table 1)
and ligated it into the Jc1/NS5A-MluI construct described below.
The SpeI-XbaI fragment from Jc1/NS5A-MluI was ligated into
SpeI/XbaI digested pSGR-JFH1. The orientation of the fragment
was confirmed by restriction enzyme digestion. pSGR-JFH1 Rz/
T7ter was constructed by fusing the antigenomic hepatitis D virus
ribozyme to the end of the HCV 39NTR using overlap extension
PCR. The T7 terminator sequence was introduced immediately
downstream of the ribozyme sequence by ligating an oligonucle-
otide linker into the XbaI restriction enzyme site.
To express T7 RNA polymerase, we added 59 BamHI and 39
EcoRI restriction sites flanking the T7 RNA polymerase coding
sequence from pOSV-T7RP [19] by PCR (primers in Table 1).
The amplified insert was digested and subcloned into BamHI/
EcoRI-digested pBABE-puro retroviral vector (Addgene plasmid
1764). VSV-G pseudotyped particles were generated as described
in [2]. Huh7.5.1 cells were transduced with retroviral particles in
the presence of 8 mg/mL polybrene (Sigma) for 4 hr at 37uC, then
selected with 2 mg/mL puromycin at 48 hr post-transduction.
For PI4KA and PI4KB silencing, T7 RNA polymerase-
expressing Huh7.5.1 cells were transduced with VSV-G pseudo-
typed lentiviral shRNA particles derived from the pLKO.1 vector.
The PI4KA shRNA sequences have been described in [2], while
the PI4KB shRNA vectors (TRC numbers 0000005695 and
0000197169) were purchased from Sigma-Aldrich. After a
minimum of 72 hours to allow for gene silencing, cells were
plated onto poly-D-lysine coated glass coverslips. The next day,
cells were transfected with pTM1(NS3-5B) or pTM1(NS3-5B/
GFP) constructs using FuGENE HD (Roche, Indianapolis, IN).
Immunofluorescence microscopy
Cells grown on poly-D-lysine coated glass coverslips were rinsed
in PBS and fixed in 4% paraformaldehyde in PBS for 15 min at
RT followed by quenching in 50 mM NH4Cl in PBS for 10 min at
RT. PI4KA immunostaining was performed as described in [20]:
cells were permeabilized in 0.5% Triton X-100 in PBS for 15 min
at RT and rinsed with PBS; blocking and antibody incubations
were performed in 3% BSA in PBS. For all other antibody
immunostaining, cells were blocked and permeabilized in 0.2%
saponin/10% FBS in PBS for 1 hour at RT. Primary antibody
incubations were performed in blocking buffer for 1 hour at RT
followed by 3 washes in PBS for 5 min each. Alexa 488 and 594-
conjugated secondary antibodies (Invitrogen) were used at a
dilution of 1:500 in blocking buffer. After 4 washes in PBS,
coverslips were mounted with ProLong Gold with DAPI
(Invitrogen) and viewed on an Olympus FluoView FV500 laser
scanning confocal microscope with sequential scanning mode to
limit crosstalk between fluorochromes.
PI 4-kinase expression constructs
N-terminal myc-tagged PI4KB subcloned into pcDNA3.1/
zeo(+) was a gift from Dr. Paul van Bergen en Henegouwen
(Universiteit Utrecht, Netherlands). 3XFLAG-tagged PI4KA in
the pFB retroviral vector has been described in [2]. The kinase-
inactive PI4KA(D1899A) mutant contains a mutation in the
conserved lipid kinase catalytic domain corresponding to the
kinase-inactivating mutation D656A reported by Godi et al. for
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extension PCR (Table 1) and the flanking restriction sites NaeI
and NotI. The amplified region was completely sequenced to
confirm that the D1899A mutation had been introduced without
any unwanted mutations.
Construction of epitope-tagged Jc1(SF) virus and affinity
purification of NS5A(SF)
The construction of Jc1 has been described in [22]. We first
introduced a unique MluI restriction site by overlap-extension
PCR (Table 1) into domain III of NS5A after aa2394 (Jc1/NS5A-
MluI), which had been previously shown to tolerate GFP insertion
[23]. We then introduced a linker encoding a N-terminal FLAG-
tag followed by a tandem Strep-tag II [24] flanked by gly-gly-ser
linkers and MluI restriction sites (Table 1). Full-length Jc1(SF)
RNA was prepared by XbaI linearization, T7 RNA transcription,
and purification as described in [25], then introduced into
Huh7.5.1 cells using a TransIT mRNA transfection kit (Mirus
Bio, Madison, WI) as described in [26]. After several rounds of
passaging in Huh7.5.1 cells, adapted Jc1(SF) virus was titered
according to [27]. Huh7.5.1 cells were infected with Jc1(SF) or
Jc1-containing cell culture supernatants at an MOI of 1 for
4 hours at 37uC. Six days post-infection, cells were harvested and
lysed in 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, and
0.5% Triton X-100 with HALT protease and phosphatase
inhibitors (Pierce, Rockford, IL). After centrifugation at 21,0006
g for 15 min at 4uC to remove insoluble material, the clarified
lysates were incubated with StrepTactin-Sepharose (IBA, Go ¨ttin-
gen, Germany) for 1 hour at 4uC. Unbound material was removed
by 3 washes in lysis buffer with 0.5% Triton X-100 followed by 3
washes in lysis buffer with 0.1% Triton X-100. Bound proteins
were eluted with lysis buffer/0.1% Triton X-100/4 mM biotin at
4uC and then separated on SDS-PAGE for immunoblotting.
Results
Silencing of the PI 4-kinase PI4KA alters membranous
web morphology
Attempts at tetracycline-inducible expression of the full-length
HCV polyprotein were unsuccessful in Huh7 or Huh7.5.1 human
hepatoma cells, although they were successful in 293T human
embryonic kidney cells (data not shown). We then turned to T7
RNA polymerase (T7RP)-driven expression [20,28] of the NS3 to
NS5B coding region from the genotype 2a JFH-1 strain under the
control of a T7 promoter and EMCV IRES (pTM1(NS3-5B);
Figure 1A). A similar construct with GFP-tagged NS5A,
pTM1(NS3-5B/GFP), was generated to facilitate colocalization
studies. The site of GFP tagging within domain III of NS5A has
been previously shown not to significantly impair viral replication
[23]. We established Huh7 cells stably expressing T7RP (Huh7/T7
cells) using a retroviral vector in order to avoid the cytotoxic effects
of vaccinia virus-based T7RP expression. The EMCV IRES was
used because the native HCV IRES yielded very low levels of
polyprotein expression in this system (not shown); however, the
resulting transcripts are incapable of RNA replication.
To demonstrate that cytoplasmically expressed T7 RNA
polymerase was able to generate authentic HCV RNA transcripts
in Huh7/T7 cells, we constructed a JFH-1 subgenomic replicon
(bearing the HCV 59 and 39 NTRs) with a hepatitis D virus
Table 1. Primers used for DNA construct preparation.
Construct Sequence




















Forward flanking primer: 59-GGAATTACGCGTGGAGGAAG
Reverse flanking primer: 59-CCTTAAACGCGTGCTTCCTC
Restriction enzymes sites are bolded.
doi:10.1371/journal.pone.0026300.t001
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HCV 39NTR followed by a T7 terminator sequence. Transfection
of the resulting JFH-1 SGR Rz/T7ter plasmid DNA into Huh7/
T7 cells followed by G418 selection resulted in a high number of
G418-resistant colonies (Figure 1B), whereas the JFH-1 SGR Rz/
T7ter construct bearing the RNA polymerase-inactivating GDD-
.GNN substitutions could not form G418-resistant colonies.
Transfection of the JFH-1 SGR Rz/T7ter DNA construct into
Huh7.5.1 cells lacking T7 RNA polymerase also failed to produce
any G418-resistant colonies (data not shown), and treatment of
G418-resistant JFH1 SGR Rz/T7ter cells with 29-C-methylade-
nosine, an inhibitor of the HCV NS5B RNA polymerase,
markedly decreased HCV NS5A expression (not shown), consis-
tent with active RNA replication.
As seen in Figure 1C/, Huh7T7 cells transfected with
pTM1(NS3-5B/GFP) displayed a punctate cytoplasmic distribu-
tion of NS3 and NS5A-GFP that is characteristic of membranous
webs [29] and that appeared similar to that seen in cells stably
expressing a JFH-1 derived subgenomic replicon. No NS3 or
NS5A-GFP expression was seen when Huh7 cells lacking T7RP
were transfected with pTM1 expression constructs (not shown).
To furtherassessthedegreeofsimilarityofthe membranousweb-
like structures generated by T7RP-driven HCV polyprotein
expression to authentic membranous webs, we performed immu-
nofluorescence staining for annexin A2, a host protein that is
recruitedbyNS5A toHCVmembranouswebs[20].Aswasthe case
in a replicon system, annexin A2 colocalized with NS5A-positive
cytoplasmic puncta in the T7 expression system (Figure 1D).
Figure 1. A nonreplicative system to study HCV membranous web formation. (A) Constructs used to express the subgenomic NS3-NS5B
polyprotein under the control of a T7 promoter. The pTM1(NS3-5B/GFP) construct contains a GFP insertion within domain III of NS5A that has been
previously shown to be compatible with viral replication [23]. (B) Recovery of replicative HCV RNA transcripts in Huh7/T7 cells stably expressing T7
RNA polymerase by a colony formation assay. Huh7/T7 cells were transfected with a DNA plasmid encoding the JFH-1 subgenomic replicon flanked
by a 59 T7 promoter and a 39 hepatitis D virus antigenomic ribozyme and T7 terminator. The NS5B GNN mutation was introduced into this construct
as a negative control. Transfected cells underwent G418 selection for three weeks and colonies were visualized by crystal violet staining. (C)
Nonreplicative expression of NS3-5B polyprotein leads to punctate membrane structures similar in morphology to membranous webs in replicon
cells. NS5A-GFP and NS3 were visualized in Huh7.5.1 hepatoma cells containing a stably replicating subgenomic HCV replicon (upper panels)
compared to Huh7/T7 cells expressing the NS3-NS5B polyprotein by T7 RNA polymerase (lower panels). Nuclei were counterstained with DAPI. Bars,
10 mm. (D) Immunostaining of subgenomic replicon-expressing cells (upper panels) and Huh7/T7 cells expressing the HCV polyprotein (lower panels)
for NS5A and for annexin A2, a host factor known to be recruited to membranous webs. Nuclei were counterstained with DAPI. Bar, 10 mm. (E) The
effect of an NS3-4A protease inhibitor on membranous web formation is readily visualized using a nonreplicative HCV expression model. Huh7.5.1
hepatoma cells containing a HCV subgenomic replicon (upper row) or expressing HCV NS3-5B by T7 RNA polymerase (lower row) were incubated
with 10 mM BILN-2061, a NS3-4A serine protease inhibitor (PI) for 48 hr and the distributions of NS3 and NS5A-GFP were visualized by confocal
immunofluorescence microscopy. Nuclei were counterstained with DAPI. Bar, 10 mm.
doi:10.1371/journal.pone.0026300.g001
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PLoS ONE | www.plosone.org 4 October 2011 | Volume 6 | Issue 10 | e26300Figure 2. PI4KA colocalizes with HCV membranous webs and its silencing leads to aberrant web morphology. (A) Silencing of PI4KA
leads to the disappearance of NS5A-GFP expression in HCV replicon cells. Huh7.5.1 cells expressing a subgenomic replicon were transduced with a
nontargeting (left) or PI4KA-targeting (right) lentiviral shRNA vector for 5 days. HCV membranous web distribution was visualized using GFP-tagged
NS5A. Bar, 20 mm. (B) Silencing of PI4KA leads to accumulation of membrane ‘‘clusters’’ in a nonreplicative model of web assembly. Huh7/T7 cells
were transduced with a nontargeting (upper row) or PI4KA-targeting (lower rows) lentiviral shRNA vector and then transfected with pTM1(NS3-5B/
GFP) to express the subgenomic NS3-5B polyprotein (with GFP-tagged NS5A). NS3 and NS4B were visualized by immunofluorescence staining and
nuclei were counterstained with DAPI. Bars, 10 mm. (C) Huh7/T7 cells transduced with a nontargeting (NT) or PI4KA-targeting shRNA vector were
transfected with pTM1(NS3-5B/GFP). Cells were then counted to determine the fraction with the membrane ‘‘cluster’’ phenotype. At least 100 cells
were counted for each condition in each of three independent experiments. Values shown are means 6 SD. (D) Colocalization of endogenous PI4KA
immunofluorescence staining with NS5A in Huh7.5.1 cells expressing a subgenomic replicon (upper panels) or in Huh7/T7 cells transfected with
pTM1(NS3-5B). Nuclei were counterstained with DAPI. Bars, 10 mm. (E) PI4KA requires kinase activity to support HCV replication. OR6 replicon cells
were transduced with MMLV retroviral vectors encoding GFP, PI4KA, or a PI4KA D1899A mutant lacking kinase activity. The cells were then
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facilitate the identification of intermediate stages in membranous
web formation. The NS3-4A serine protease releases the mature
HCV nonstructural proteins by post-translational cleavage of the
HCV polyprotein, and is absolutely required for viral replication.
We examined the distribution of NS3 and NS5A-GFP by confocal
microscopy in the T7RP expression system versus replicon cells
treated with the NS3-4A protease inhibitor BILN-2061 [30].
While 48 hours of treatment with 10 mM BILN-2061 resulted in
the near-complete disappearance of NS3 and NS5A-GFP
expression in replicon cells, protease inhibitor treatment of
Huh7/T7 cells transfected with pTM1(NS3-5B/GFP) resulted in
redistribution of NS3 and NS5A-GFP to a prominent reticular
pattern consistent with ER localization and the absence of a
membranous web pattern (Figure 1E). We conclude that
nonreplicative expression of HCV proteins can be used to study
intermediate events in membranous web formation that would not
be readily discerned using authentic replication systems.
Similarly, silencing of PI4KA using a lentiviral shRNA vector led
to the complete disappearance of HCV nonstructural protein
expression in replicon cells (Figure 2A). In contrast, PI4KA silencing
followed by T7RP-driven HCV expression in Huh7.5.1 cells led to
the appearance of NS5A and NS3-positive membrane ‘‘clusters’’
within the cytoplasm (Figures 2B and 2C) similar in morphology to
those that we had previously observed in U2-OS cells [2]. Moreover,
these membrane ‘‘clusters’’ also contained HCV NS4B, an integral
membrane protein that is essential for membranous web formation
(Figure2B).TheseobservationssuggestthatPI4KAisessentialforthe
maturation of HCV-associated host membranes into replication-
competent membranous webs. If true, then PI4KA should associate
with HCV-associated membranes at some point during membranous
web formation. Indeed, we found that endogenous PI4KA
colocalized with membranous webs in a JFH1 subgenomic replicon
cell line as well as in Huh7/T7 cells (Figure 2D).
To determine whether PI4KA’s kinase activity is required for its
ability to support HCV replication, we asked whether a kinase-
dead PI4KA mutant could rescue viral replication in cells silenced
for endogenous PI4KA. PI4KA(D1899A) lacking in vitro kinase
activity [31] or wild-type PI4KA was expressed in OR6 replicon
cells by retroviral transduction. The OR6 replicon contains a full-
length genotype 1b HCV genome and a Renilla luciferase reporter
gene [16]. Both PI4KA constructs lack the 39UTR and are
therefore resistant to a shRNA targeting the PI4KA 39UTR, while
the endogenous PI4KA transcript is efficiently silenced [2].
Expression of shRNA-resistant wild-type PI4KA rescued HCV
replication in OR6 cells silenced for endogenous PI4KA, while the
kinase-dead PI4KA(D1899A) mutant could not rescue viral
replication in OR6 cells silenced for endogenous PI4KA
(Figure 2E), upper panel. Silencing of endogenous PI4KA and
expression of exogenous PI4KA constructs was confirmed by
immunoblotting (Figure 2E), lower panel.
PI4KA interacts with NS5A in HCV-infected cells
Because PI4KA appears to play an essential role in HCV web
formation and localizes to membranous webs, we hypothesized
that it interacts with one or more viral proteins. As depicted in
Figure 3A-, we inserted a small tandem affinity purification tag
consisting of a tandem Streptag II and a FLAG tag [24] into
domain III of NS5A at a site previously shown to be tolerant of
other insertions such as GFP [23]; the backbone used was the
chimeric genotype 2a Jc1 (J6/JFH1) genome [22], which is fully
infectious in cell culture. The short Strep-tag II epitope tag binds
to Strep-Tactin, an engineered streptavidin, and can be eluted
with biotin or desthiobiotin. The resulting Jc1(SF) virus remains
infectious in cell culture, and with several passages in cell culture
became cell culture-adapted, reaching viral titers of .8610
6
TCID50/mL, comparable to wild-type Jc1 virus. Immunostaining
revealed strong anti-FLAG immunoreactivity among Jc1(SF)-
infected Huh7.5.1 cells, while no anti-FLAG reactivity was seen
among wild-type Jc1-infected cells (Figure 3B). The epitope tag
insertion was genetically stable, as evidenced by retention of
FLAG immunoreactivity in all infected cells after cell culture
adaptation. DAPI nuclear counterstaining also demonstrated
virtually complete infection of Huh7.5.1 cells by the Jc1(SF) virus.
NS5A(SF) was isolated using Strep-Tactin-conjugated beads
from lysates of Jc1(SF)-infected Huh7.5.1 cells. Wild-type Jc1 was
used as a negative control. Bound NS5A(SF) and associated
proteins were eluted with biotin and separated on SDS-PAGE for
immunoblotting. The depleted lysate after Strep-Tactin binding
was also evaluated to assess the degree of protein binding. We
found that while untagged NS5A failed to bind to Strep-Tactin
(Figure 3C), lane 3, NS5A(SF) was efficiently captured by the
affinity matrix. Indeed, under the binding conditions used,
virtually all of the NS5A(SF) was bound (Figure 3C), lanes 5 and
6. Immunoblotting revealed that PI4KA copurified with NS5A(SF)
but not with untagged NS5A, consistent with a direct or indirect
association between PI4KA and NS5A.
Phosphatidylinositol 4-phosphate is enriched on HCV
membranous webs
Since endogenous PI4KA is found on HCV membranous webs,
and because kinase-dead PI4KA does not support HCV
replication, we reasoned that the product of PI4KA, phosphati-
dylinositol 4-phosphate, should be enriched on HCV membranous
webs. Immunostaining with an anti-PI(4)P monoclonal antibody
revealed enrichment of PI(4)P at HCV membranous webs in JFH1
subgenomic replicon cells as well as in the T7 expression system
(Figure 4A). This observation, coupled with our previous annexin
A2 and PI4KA immunostaining data, provides additional evidence
that T7RP-driven HCV polyprotein expression is a good model
for HCV membranous web formation.
On the other hand, the membrane clusters induced by PI4KA
silencing in the T7 HCV expression system were negative for
PI(4)P immunolabeling (Figure 4B), demonstrating that PI(4)P
enrichment at HCV membranous webs requires PI4KA. Further-
more, this strongly suggests that the observed anti-PI(4)P
immunoreactivity at HCV membranous webs is specific, and not
due to nonspecific binding of the antibody to webs.
PI4KB supports the HCV life cycle but does not localize to
or generate PI(4)P at membranous webs
Two RNAi screens have also identified the related PI 4-kinase
PI4KB as a host cofactor of HCV replication [3,32]. We have
previously shown that PI4KB overexpression does not rescue the
transduced 24 h later with lentiviral vectors encoding a nontargeting shRNA (black bars) or a shRNA targeting the PI4KA 39UTR (white bars) to silence
endogenous PI4KA. Cells were assayed 96 h after lentiviral transduction (upper panel). Values were obtained from quadruplicate wells in two
independent experiments and are plotted as means 6 SD. Cells in duplicate wells were lysed for immunoblotting for PI4KA, anti-FLAG, and beta-actin
(lower panel) to confirm PI4KA silencing and PI4KA construct expression. PI4KA band intensities were quantitated by densitometric analysis using NIH
ImageJ software and normalized to beta-actin.
doi:10.1371/journal.pone.0026300.g002
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PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26300Figure 3. PI4KA interacts with NS5A in HCV-infected cells. (A) Schematic of the Jc1(SF) viral genome containing a tandem Strep-tag II and a
FLAG tag in domain III of NS5A. (B) Productive infection of hepatoma cells with the Jc1(SF) virus. Huh7.5.1 cells were infected with wild-type Jc1
(upper panels) and culture-adapted Jc1(SF) viruses at an MOI of 1, fixed at six days after infection, and immunostained for NS5A (left panels) and FLAG
(right panels). Nuclei were visualized by DAPI staining. (C) PI4KA associates with epitope-tagged NS5A in Jc1(SF)-infected cells. Lysates prepared from
Huh7.5.1 cells infected six days prior with either wild-type Jc1 or culture-adapted Jc1(SF) were incubated with Strep-Tactin-conjugated beads.
Unbound proteins were saved for analysis. After washing, NS5A(SF) and interacting proteins (‘‘bound’’) were eluted with biotin. Samples were
separated by SDS-PAGE and immunoblotted for PI4KA, NS5A, and beta-actin.
doi:10.1371/journal.pone.0026300.g003
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PI4KB supports a step in viral replication that is distinct from
PI4KA. Two independent lentiviral shRNA constructs targeting
PI4KB were used to silence PI4KB in Huh7.5.1 cells, followed by
infection with a Jc1/Gluc2A virus encoding a secreted Gaussia
luciferase reporter [22]. 72 hours after infection, Gaussia activity in
the supernatant was assayed and the cells were subjected to lysis
for immunoblotting. As seen in Figure 5A/, both PI4KB shRNAs
did inhibit Jc1Gluc2A in a dose-dependent manner, though not as
strongly as with PI4KA silencing. Immunoblotting revealed that
PI4KB was depleted by both PI4KB-specific shRNAs and showed
that PI4KB silencing was associated with a dose-dependent
decrease in NS5A protein levels (Figure 5B).
Furthermore, no association between endogenous PI4KB and
epitope-tagged NS5A was identified in Jc1(SF)-infected cells
(Figure 5C) under the conditions used to demonstrate the
association of PI4KA with NS5A.
At steady-state, PI4KB predominantly localizes to the Golgi
[21], and is recruited to enterovirus-induced host membrane
alterations [10]. In SGR-JFH1(NS5A-GFP) replicon cells trans-
fected with a myc-PI4KB expression construct, myc-PI4KB was
found to be distributed in a pattern consistent with a Golgi
membrane localization, and did not colocalize with HCV
membranous webs (Figure 5D). Furthermore, silencing of PI4KB
did not cause any apparent alterations in web morphology in the
T7 expression system (Figure 5E), nor did it lead to the loss of
Figure 4. PI(4)P is enriched on HCV membranous webs. (A) PI(4)P immunostaining colocalizes with NS5A(GFP) at HCV membranous webs in
replicon-expressing Huh7.5.1 cells (upper panels) as well as in T7-driven nonreplicative expression of NS3-5B (lower panels). Nuclei were
counterstained with DAPI. Bar, 10 mm. (B) The membrane clusters induced by PI4KA silencing in the T7 expression model are negative for PI(4)P
immunostaining. Huh7/T7 cells were silenced for PI4KA using lentiviral shRNA expression and then transfected with pTM1(NS3-5B/GFP) 24 hr prior to
fixation and immunolabeling for PI(4)P. Nuclei were counterstained with DAPI. Bar, 10 mm.
doi:10.1371/journal.pone.0026300.g004
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fore, the enrichment of PI(4)P at membranous webs appears to be
due to the activity of PI4KA and does not require PI4KB. We
conclude that while PI4KB may support HCV replication, its
function appears to be different from that of PI4KA.
PI4KA silencing-induced membrane clustering depends
on HCV polyprotein cleavage but does not require
integrity of the ER-Golgi secretory pathway
The ability to study HCV membranous web assembly without
ongoing viral replication allows us to study interactions between
two events or host genes that are required for HCV web assembly.
As proof-of-concept, we first hypothesized that HCV nonstructural
protein cleavage by the NS3-4A viral protease is required for the
accumulation of NS5A-positive membrane clusters in PI4KA-
silenced cells. T7-driven expression of HCV NS3-5B in PI4KA
silenced cells led to the formation of membrane clusters
(Figure 6A), as expected. However, addition of the NS3-4A
protease inhibitor BILN-2061 to PI4KA-silenced cells led to
inhibition of membrane cluster formation (Figures 6A and 6C),
demonstrating that formation of this membranous web interme-
diate requires posttranslational cleavage of the viral nonstructural
proteins [33].
Figure 5. PI4KB silencing inhibits HCV infection but does not affect membranous web formation. (A) PI4KB silencing inhibits HCV
infection. Huh7.5.1 cells were transduced with a nontargeting lentiviral shRNA construct or shRNA constructs targeting PI4KA or PI4KB. Two
independent PI4KB-targeting shRNA vectors were used at two different doses. shRNA-transduced cells were infected with a Jc1/Gluc2A reporter virus
encoding a Gaussia luciferase reporter gene. 72 hr after infection, luciferase activity in the supernatant was assayed and normalized to cells
transduced with the nontargeting shRNA. Values represent means 6 SD from triplicate wells in two independent experiments. (B) Cell lysates
prepared from cells transduced with nontargeting, PI4KA, or PI4KB shRNA vectors and infected with Jc1/Gluc2A as in (A) were separated by SDS-PAGE
and immunoblotted for PI4KA, PI4KB, NS5A, and beta-actin. PI4KA and PI4KB band intensities were quantitated by densitometric analysis using NIH
ImageJ software and normalized to beta-actin. (C) PI4KB does not interact with NS5A in HCV-infected cells. Lysates prepared from Huh7.5.1 cells
infected with Jc1(SF) virus were incubated with Strep-Tactin-conjugated beads. Unbound proteins were saved for analysis. After washing, NS5A(SF)
and interacting proteins (‘‘bound’’ lane) were eluted with biotin. Samples were separated by SDS-PAGE and immunoblotted for PI4KA, PI4KB, and
NS5A. (D) PI4KB does not colocalize with membranous webs. Huh7.5.1 stably expressing the SGR-JFH1(NS5A-GFP) replicon were transiently
transfected with a myc-PI4KB construct and immunostained with an anti-myc antibody. Bars, 10 mm. (E) PI4KB silencing does not alter membranous
web morphology in the T7 HCV expression system. Huh7/T7 cells were silenced with the PI4KB shRNA #1 construct used in (A) and (B) prior to
transfection with pTM1(NS3-5B/GFP). Cells were immunostained with anti-NS3 and NS5A-GFP was visualized by GFP fluorescence. Nuclei were
counterstained with DAPI. Bar, 10 mm. (F) PI4KB silencing does not lead to loss of PI(4)P immunoreactivity at membranous webs. Huh7/T7 cells were
silenced for PI4KB prior to transfection with pTM1(NS3-5B/GFP). Cells were immunostained with anti-PI(4)P and nuclei were counterstained with DAPI.
Bar, 10 mm.
doi:10.1371/journal.pone.0026300.g005
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silenced cells requires an intact ER-Golgi secretory pathway.
Brefeldin A (BFA) inhibits ADP ribosylation factors such as ARF1
by targeting guanine nucleotide exchange factors such as GBF1.
ARF1 inhibition, in turn, disrupts early secretory membrane
trafficking by preventing COPI coat assembly. ARF1, GBF1, and
COPI coatomer have all been shown to be cofactors of HCV
replication [2,34,35]. BFA inhibits HCV replication when added
at the time of or shortly after infection but is less effective at
inhibiting replication after infection has been established [2],
suggesting that GBF1 and ARF1 act early in the viral lifecycle. We
initially hypothesized that these factors could interfere with
membranous web formation. We found, however, that BFA
treatment at 100 ng/mL, a dose sufficient to inhibit HCV
replication [2] and cause dissociation of beta-COP from the
Golgi, failed to prevent the formation of NS5A-positive membrane
clusters in PI4KA-silenced cells (Figures 6B and 6C) or the
formation of NS5A-positive puncta in nontargeting shRNA
control cells. These findings suggest that GBF1, ARF1, and COPI
act downstream of PI4KA in the HCV lifecycle and that
membrane cluster formation does not require an intact early
secretory pathway.
Discussion
It has been known for decades that a number of viruses induce
membrane alterations within the infected host cell [36]. This
appears to be universally true among positive-sense RNA viruses
such as HCV, and has been postulated to shield viral RNA and
other pathogen-associated molecular patterns from host innate
immune recognition and defenses. Electron tomographic studies of
dengue-infected cells have demonstrated the induction of a
complex network of ER-derived interconnected membranes of
varying morphologies [37]. However, our understanding of the
molecular mechanisms that direct these membrane alterations has
lagged behind their morphologic characterization. One reason for
this has been our incomplete understanding of the cellular factors
that are exploited by HCV for membranous web assembly. Recent
RNAi screens have identified previously unknown host depen-
dency factors, such as PI4KA, that are essential for HCV
Figure 6. HCV-induced membrane clustering in PI4KA-silenced cells requires NS3-4A protease activity but does not require host
secretory pathway integrity. (A) Formation of membrane ‘‘clusters’’ in PI4KA-silenced cells expressing HCV proteins requires HCV polyprotein
cleavage. Huh7/T7 cells were transduced with a nontargeting (upper panels) or a PI4KA-targeting (lower panels) shRNA vector prior to pTM1(NS3-5B)
transfection. Cells were treated with 0.5% DMSO (left panels) or with 10 mM BILN-2061 (right panels) for 24 hours prior to fixation and
immunostaining for NS5A. Nuclei were counterstained with DAPI. Bar, 10 mm. (B) Formation of membrane ‘‘clusters’’ in PI4KA-silenced cells
expressing HCV proteins does not require integrity of the host secretory pathway. Huh7/T7 cells were transduced with a nontargeting (upper panels)
or a PI4KA-targeting (lower panels) shRNA vector prior to pTM1(NS3-5B) transfection. Upon transfection, cells were treated with 0.1% ethanol or with
100 ng/mL BFA for 24 hours prior to fixation and immunostaining for NS5A and beta-COP (to demonstrate COPI coatomer dispersal by BFA). Nuclei
were counterstained with DAPI. Bar, 10 mm. (C) Cells from the experiments shown in panels (A) and (B) were counted to determine the fraction with
the membrane ‘‘cluster’’ phenotype. A minimum of 100 cells were counted for each condition in each of two independent experiments. Values
shown are means 6 SD.
doi:10.1371/journal.pone.0026300.g006
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important for web formation. Another reason has been the
dependence of HCV polyprotein expression on active viral RNA
replication. At the long timescales needed for RNAi experiments,
silencing of factors required for the viral lifecycle leads to the loss
of new membranous web formation in models that depend on
active viral RNA replication, such as replicons or cell culture-
infectious HCV. In order to circumvent this limitation, non-
replicative systems of HCV polyprotein expression and web
formation must be used.
In our previous work, we found that PI4KA silencing led to the
formation of NS5A-positive membrane clusters in a U2-OS
osteosarcoma cell line model of inducible HCV polyprotein
expression [2,14]. However, studies of HCV membranous web
assembly are better performed in a more physiologically relevant
hepatocyte cell line. In this study, we used a T7 RNA polymerase-
based expression system [20,28] in Huh7 human hepatoma cells to
study the roles of PI4KA and PI4KB on HCV membranous web
assembly. T7RP-driven expression of the HCV NS3-5B poly-
protein results in the generation of structures that are similar to
authentic HCV membranous webs based on their morphology,
subcellular distribution, and the presence of common viral and
host markers (NS5A, NS3, annexin A2, PI(4)P, and PI4KA).
During the preparation of this manuscript, two other groups
reported their work on PI4KA and HCV replication [6,39]. Reiss et
al. found colocalization of PI(4)P and PI4KA, but not PI4KB, with
the HCV membranous web and showed that nonreplicative
expression of HCV nonstructural proteins in PI4KA-silenced cells
induced clusters of small double-membrane vesicles. Both groups
found that cellular PI(4)P levels were increased in HCV-infected
cells in a PI4KA-dependent manner, and that NS5A stimulated
PI4KA lipid kinase activity in vitro. Our findings substantially agree
with both of these studies. In addition, we propose that the HCV-
induced membrane ‘‘clusters’’ seen in PI4KA silenced cells
represent accumulation of a specific intermediate in HCV
membranous web formation. The generation of these clusters from
their cellular membrane(s) of origin does not require PI4KA, thus
defining an early stage in host membrane rearrangement that is
PI4KA and PI(4)P-independent. In addition, we show that
formation of the HCV-induced membrane clusters seen in PI4KA
silenced cells requires NS3-4A serine protease activity, suggesting
that cluster formation requires the specific activities of one or more
viral nonstructural proteins and is not merely a nonspecific effect of
the T7RP expression system. Finally, formation of this HCV
membranous web intermediate is resistant to BFA treatment and is
therefore not dependent on integrity of the ER-Golgi secretory
pathway. This result is consistent with the model that the HCV
membranous web arises directly from the ER; if the web were
produced from a post-ER membrane compartment, we would
expect cluster formation to be BFA-sensitive. The mechanism by
which ARF1, GBF1, and COPI support HCV replication remains
to be elucidated. Goueslain et al. have shown that BFA treatment of
HCV-infected Huh7 cells results in ultrastructural disorganization
of membranous web structure, but BFA treatment does not prevent
the appearance of membranous web-like structures in U2-OS cells
induced to express the HCV polyprotein [34]. Our findings that
membrane cluster formation is insensitive to BFA treatment agrees
with their conclusion that BFA-sensitive factors are not required for
web morphogenesis, but perhaps for web activity.
The association of PI4KA with HCV-induced membrane
alterations is likely to stimulate the local generation of PI(4)P. Of
note, while PI4KB does not appear to be recruited to HCV
membranous webs, it is associated with enteroviral membrane
alterations [10], suggesting that local PI(4)P production may be
necessary for the replication of a number of positive-sense RNA
viruses. It remains to be determined whether other positive-sense
viruses hijack other PI 4-kinase family members for their own
replication. If so, this would raise the possibility that strategies to
disrupt viral-induced PI(4)P accumulation might have activity
against multiple positive-sense RNA viruses.
Subsequent steps in membranous web formation have yet to be
defined, but are likely to involve the recruitment of host and/or
viral PI(4)P-binding protein(s). For instance, the poliovirus 3D
RNA polymerase binds to PI(4)P in a protein-lipid overlay assay
[10], suggesting a mechanism by which viral components might be
recruited and/or retained at replication sites. It remains to be
determined whether any HCV proteins interact directly with
PI(4)P. Alternatively or additionally, host PI(4)P binding proteins
could be recruited to the maturing HCV membranous web. One
candidate is oxysterol-binding protein (OSBP), which binds to
PI(4)P and has also been shown to regulate HCV particle assembly
[40]. Future studies will seek to identify the effectors of PI4KA and
PI(4)P at the HCV membranous web.
One limitation of this work is the identification of only two
intermediates in web formation: the relatively trivial ER retention
pattern shown by NS3-4A protease inhibition, and the PI(4)P-
negative membrane clusters revealed by PI4KA inhibition.
Inhibiting other known host factors of HCV replication in
nonreplicative web formation systems may lead to the identifica-
tion of additional intermediate stages of HCV web formation. In
addition, we will need to move beyond morphological descriptions
of membranous webs and their intermediates, as these will be
reliable only for extreme phenotypes. More sensitive and specific
techniques to dissect web assembly mechanisms might include the
identification of additional reliable markers of the web and its
intermediates (such as PI(4)P), and the characterization of their
biochemical and biophysical properties.
Acknowledgments
Huh 7.5.1 cells, myc-PI4KB expression vector, Jc1 and Jc1/Gluc2A
viruses, pTM1 and pOSV-T7RP vectors, anti-NS5A monoclonal antibody
(clone 9E10), and JFH1-SGR subgenomic replicon were gifts from Dr.
Francis Chisari (Scripps Institute, La Jolla, CA), Dr. Paul van Bergen en
Henegouwen (Universiteit Utrecht, Netherlands), Dr. Brett Lindenbach
(Yale University, New Haven, CT), Dr. Bernard Moss (National Institutes
of Health, Bethesda, MD), Dr. Charles Rice (Rockefeller University, New
York, NY), and Dr. Takaji Wakita (National Institute of Infectious
Diseases, Tokyo, Japan), respectively.
Author Contributions
Conceived and designed the experiments: AT SS. Performed the
experiments: AT SS. Analyzed the data: AT SS. Wrote the paper: AT.
References
1. Reesink HW, Zeuzem S, Weegink CJ, Forestier N, van Vliet A, et al. (2006)
Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a
phase Ib, placebo-controlled, randomized study. Gastroenterology 131:
997–1002.
2. Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, et al. (2009) A functional
genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell
Host and Microbe 5: 298–307.
3. Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, et al. (2009) Class III
phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of
hepatitis C virus replication. Journal of Virology 83: 10058–10074.
4. Berger KL, Cooper JD, Heaton NS, Yoon R, Oakland TE, et al. (2009) Roles
for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis
C virus replication. Proceedings of the National Academy of Sciences of the
United States of America 106: 7577–7582.
Role of the PI 4-Kinase PI4KA in HCV Replication
PLoS ONE | www.plosone.org 11 October 2011 | Volume 6 | Issue 10 | e263005. Vaillancourt FH, Pilote L, Cartier M, Lippens J, Liuzzi M, et al. (2009)
Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA
replication. Virology 387: 5–10.
6. Reiss S, Rebhan I, Backes P, Romero-Brey I, Erfle H, et al. (2011) Recruitment
and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity
of the membranous replication compartment. Cell Host and Microbe 9: 32–45.
7. Balla A, Balla T (2006) Phosphatidylinositol 4-kinases: old enzymes with
emerging functions. Trends in Cell Biology 16: 351–361.
8 .W a n gY J ,W a n gJ ,S u nH Q ,M a r t i n e zM ,S u nY X ,e ta l .( 2 0 0 3 )
Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1
complexes to the Golgi. Cell 114: 299–310.
9. D’Angelo F, Vicinanza M, Di Campli A, De Matteis MA (2008) The multiple
roles of PtdIns(4)P - not just the precursor of PtdIns(4,5)P2. Journal of Cell
Science 121: 1955–1963.
10. Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, et al. (2010) Viral
reorganization of the secretory pathway generates distinct organelles for RNA
replication. Cell 141: 799–811.
11. Egger D, Wo ¨lk B, Gosert R, Bianchi L, Blum HE, et al. (2002) Expression of
hepatitis C virus proteins induces distinct membrane alterations including a
candidate viral replication complex. Journal of Virology 76: 5974–5984.
12. Shi ST, Lee KJ, Aizaki H, Hwang SB, Lai MM (2003) Hepatitis C virus RNA
replication occurs on a detergent-resistant membrane that cofractionates with
caveolin-2. Journal of Virology 77: 4160–4168.
13. Stone M, Jia S, Do Heo W, Meyer T, Konan KV (2007) Participation of Rab5,
an early endosome protein, in hepatitis C virus RNA replication machinery.
Journal of Virology 81: 4551–4563.
14. Schmidt-Mende J, Bieck E, Hu ¨gle T, Penin F, Rice CM, et al. (2001)
Determinants for membrane association of the hepatitis C virus RNA-dependent
RNA polymerase. Journal of Biological Chemistry 276: 44052–44063.
15. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, et al. (2005) Robust
hepatitis C infection in vitro. Proceedings of the National Academy of Sciences
of the United States of America 102: 9294–9299.
16. Ikeda M, Abe K, Dansako H, Nakamura T, Naka K, et al. (2005) Efficient
replication of a full-length hepatitis C virus genome, strain O, in cell culture, and
development of a luciferase reporter system. Biochemical and Biophysical
Research Communications 329: 1350–1359.
17. Kato T, Date T, Miyamoto M, Furusaka A, Tokushige K, et al. (2003) Efficient
replication of the genotype 2a hepatitis C virus subgenomic replicon.
Gastroenterology 125: 1808–1817.
18. Moss B, Elroy-Stein O, Mizukami T, Alexander WA, Fuerst TR (1990) Product
review. New mammalian expression vectors. Nature 348: 91–92.
19. Elroy-Stein O, Moss B (1990) Cytoplasmic expression system based on
constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian
cells. Proceedings of the National Academy of Sciences of the United States of
America 87: 6743–6747.
20. Backes P, Quinkert D, Reiss S, Binder M, Zayas M, et al. (2010) Role of annexin
A2 in the production of infectious hepatitis C virus particles. Journal of Virology
84: 5775–5789.
21. Godi A, Pertile P, Meyers R, Marra P, Di Tullio G, et al. (1999) ARF mediates
recruitment of PtdIns-4-OH kinase-beta and stimulates synthesis of
PtdIns(4,5)P2 on the Golgi complex. Nature Cell Biology 1: 280–287.
22. Phan T, Beran RK, Peters C, Lorenz I, Lindenbach BD (2009) Hepatitis C virus
NS2 protein contributes to virus particle assembly via opposing epistatic
interactions with the E1-E2 glycoprotein and NS3-4A enzyme complexes.
Journal of Virology 83: 8379–8395.
23. Moradpour D, Evans MJ, Gosert R, Yuan Z, Blum HE, et al. (2004) Insertion of
green fluorescent protein into nonstructural protein 5A allows direct visualiza-
tion of functional hepatitis C virus replication complexes. Journal of Virology 78:
7400–7409.
24. Gloeckner CJ, Boldt K, Schumacher A, Roepman R, Ueffing M (2007) A novel
tandem affinity purification strategy for the efficient isolation and characterisa-
tion of native protein complexes. Proteomics 7: 4228–4234.
25. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, et al. (2006) Cell
culture and infection system for hepatitis C virus. Nature Protocols 1:
2334–2339.
26. Gonzalez G, Pfannes L, Brazas R, Striker R (2007) Selection of an optimal RNA
transfection reagent and comparison to electroporation for the delivery of viral
RNA. Journal of Virological Methods 145: 14–21.
27. Lindenbach BD (2009) Measuring HCV infectivity produced in cell culture and
in vivo. Methods in Molecular Biology 510: 329–336.
28. Chung RT, He W, Saquib A, Contreras AM, Xavier RJ, et al. (2001) Hepatitis
C virus replication is directly inhibited by IFN-alpha in a full-length binary
expression system. Proceedings of the National Academy of Sciences of the
United States of America 98: 9847–9852.
29. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, et al. (2003)
Identification of the hepatitis C virus RNA replication complex in Huh-7 cells
harboring subgenomic replicons. Journal of Virology 77: 5487–5492.
30. Lamarre D, Anderson PC, Bailey M, Beaulieu P, Bolger G, et al. (2003) An NS3
protease inhibitor with antiviral effects in humans infected with hepatitis C virus.
Nature 426: 186–189.
31. Tai AW, Bojjireddy N, Balla T (2011) A homogeneous and nonisotopic assay for
phosphatidylinositol 4-kinases. Analytical Biochemistry 417: 97–102.
32. Trotard M, Lepe `re-Douard C, Re ´geard M, Piquet-Pellorce C, Lavillette D, et al.
(2009) Kinases required in hepatitis C virus entry and replication highlighted by
small interference RNA screening. FASEB Journal 23: 3780–3789.
33. Ng CY, Gu F, Phong WY, Chen YL, Lim SP, et al. (2007) Construction and
characterization of a stable subgenomic dengue virus type 2 replicon system for
antiviral compound and siRNA testing. Antiviral Research 76: 222–231.
34. Goueslain L, Alsaleh K, Horellou P, Roingeard P, Descamps V, et al. (2010)
Identification of GBF1 as a cellular factor required for hepatitis C virus RNA
replication. Journal of Virology 84: 773–787.
35. Matto M, Sklan EH, David N, Melamed-Book N, Casanova JE, et al. (2011)
Role for ADP Ribosylation Factor 1 in the regulation of Hepatitis C virus
replication. Journal of Virology 85: 946–956.
36. Pfeifer U, Thomssen R, Legler K, Bo ¨ttcher U, Gerlich W, et al. (1980)
Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in
hepatocytes of infected chimpanzees. Virchows Archive B: Cell Pathology
Including Molecular Pathology 33: 233–243.
37. Welsch S, Miller S, Romero-Brey I, Merz A, Bleck CK, et al. (2009)
Composition and three-dimensional architecture of the dengue virus replication
and assembly sites. Cell Host and Microbe 5: 365–375.
38. Li Q, Brass AL, Ng A, Hu Z, Xavier RJ, et al. (2009) A genome-wide genetic
screen for host factors required for hepatitis C virus propagation. Proceedings of
the National Academy of Sciences of the United States of America 106:
16410–16415.
39. Berger KL, Kelly SM, Jordan TX, Tartell MA, Randall G (2011) Hepatitis C
virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phospha-
tidylinositol 4-phosphate production that is essential for its replication. Journal of
Virology.
40. Amako Y, Sarkeshik A, Hotta H, Yates J, 3rd, Siddiqui A (2009) Role of
oxysterol binding protein in hepatitis C virus infection. Journal of Virology 83:
9237–9246.
Role of the PI 4-Kinase PI4KA in HCV Replication
PLoS ONE | www.plosone.org 12 October 2011 | Volume 6 | Issue 10 | e26300